2:26
Benefits of performing outpatient transplant
Jeanne McCarthy-Kaiser
1:09
Treating GvHD: current challenges and newly approved drugs
Katie Gatwood
1:43
The importance of pharmacist intervention in the treatment of GvHD with ruxolitinib and ibrutinib
Katie Gatwood
2:29
Ruxolitinib and ibrutinib: the future for GvHD treatment?
Katie Gatwood
1:29
The introduction of biosimilar rituximab: a case study from the pharmacist’s perspective
Simon Cheesman
4:02
Improving the Cancer Journey: update and the role of pharmacists
Trisha Hatt
1:54
Improving the NICE drug approval process
Man-Chie Chow
1:58
The importance of BOPA
Islam Elkonaissi
1:53
The introduction of novel immunotherapies and the pharmacist
Islam Elkonaissi
0:57
How pharmacists and patients can effectively use Macmillan Cancer Support
Fiona Smith
2:19
How services outside of primary and secondary care settings can help cancer patient’s treatment
Fiona Smith
1:01
BOPA 2017: What are the hot topics?
Carl Booth
2:30
Selecting the best abstracts for presentation at BOPA
Carl Booth
1:47
Driving efficiency improvements in the NHS
Bryn Thomas
3:33
The developing role of pharmacist prescribers
Bryn Thomas
2:37
The potential for patient-level data in the NHS
Bryn Thomas
VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJHO needs the contact information you provide to inform you about our latest hemonc news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

The content of VJHemOnc is intended for healthcare professionals